about
Functional characterization of the human atrial essential myosin light chain (hALC-1) in a transgenic rat modelEpigenetic regulation of insulin-like growth factor axis in hepatocellular carcinomaHuman atrial myosin light chain 1 expression attenuates heart failurePredictive prognostic role of miR-181a with discrepancy in the liver and serum of genotype 4 hepatitis C virus patientsMir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor.Expression signature of microRNA-155 in hepatitis C virus genotype 4 infection.Functional characterization of Fospeg, and its impact on cell cycle upon PDT of Huh7 hepatocellular carcinoma cell model.Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma.miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.Sex hormones and HCV: an unresolved mystery.Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models.Epigenetic harnessing of HCV via modulating the lipid droplet-protein, TIP47, in HCV cell models.miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern.miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients.miR-148a and miR-30a limit HCV-dependent suppression of the lipid droplet protein, ADRP, in HCV infected cell models.MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc.Progesterone suppresses interferon signaling by repressing TLR-7 and MxA expression in peripheral blood mononuclear cells of patients infected with hepatitis C virus.Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma.Dual downregulation of microRNA 17-5p and E2F1 transcriptional factor in pediatric systemic lupus erythematosus patients.Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression.Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma.Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-α/BAFF axis pathway by miR-155.Tamoxifen downregulates MxA expression by suppressing TLR7 expression in PBMCs of males infected with HCV.Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to Viral Infectivity in HCV Cell Models.Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients.Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients.Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth.Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular CarcinomaExpression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosusCompeting Endogenous RNAs in Hepatocellular Carcinoma-The Pinnacle of Rivalry
P50
Q24312757-B1388AFF-F75F-4113-BEFA-3E3CAD8F10D8Q26766068-42107D85-E30C-44C6-8B0D-2953B1C3C0C0Q28267707-2C71FEA8-0781-4B4F-AA98-F0C9E4A1AA7AQ34265451-0C1CDE78-290E-46B1-8F45-F2C1DEEBE7E2Q34438412-599DD185-FA54-4412-BADF-D7103074E040Q34608134-7128CDE9-5881-4D4B-93E6-FD6B1A22CE38Q34610280-B805F3E8-06C8-46E1-8EEF-816838B055C1Q37188567-524867A9-6A1F-4142-960D-69149F5F678FQ37578279-BA4E5136-D175-4381-868D-D37FF5BA2252Q37578281-36F4DCA6-52CF-4247-9401-251012A77B4EQ38069609-D9125EC0-6C56-4F15-AF30-1392B14DA672Q38766496-98D001EC-66FE-474C-8609-B261F6428D78Q38823504-554E2437-DEFE-4039-9DB2-1BDD9C6DB61FQ38830865-1F7942A1-C6F3-472B-9C07-059941FAB62AQ38853505-46582A70-23BA-4D39-A411-337E499929E6Q38854666-983D5042-795A-420B-9527-B7AFB5CF808EQ38903604-6379E751-6783-4AF0-A305-D09EAC316F65Q39167165-74266CBE-F15B-4B97-AABC-905C4A65A0D1Q39310720-56C25690-EF35-462A-AFFC-FC70CF278015Q40148655-FCA745A2-C7E6-47F9-A7C7-9889AE762D6BQ40189561-4E3DA607-91A9-4806-8369-D6795CFF8E9CQ40552844-45AEBCB6-E412-47C5-ABAA-C4F94EC2546EQ40555570-5851D06B-822E-44F5-B71F-6E15FCAFB760Q42990490-E9F0AF86-BD58-4012-8C68-E1722839947AQ43036965-B40DB852-29EB-4596-9D07-7FC59E320D20Q43147470-EC28680F-4B01-4594-88F6-8EED565066B3Q44357614-D3476B18-1343-45F1-85B5-CB403F629D55Q46617197-D03ABB2B-B09D-4BE2-94C6-E48FCB1B99A0Q46726605-B5C12679-4583-42D6-A4F8-158D1BEF3FDCQ48122826-526AEFE5-ADF8-4EF4-B1B9-610755112A6AQ50904609-2F6A5B9C-B3F7-4BDE-9FD3-E42E2FB829FBQ51154800-A440B347-7453-4727-981A-9CB426B7E8CEQ52332712-274B0B2D-CB99-45CF-8C3D-67B8BD4169A9Q52639298-2DA363A5-9498-4807-90FE-9DA8E18B948DQ53141065-BF5EE362-032D-49FE-9649-765C008AECFFQ53426107-1466821F-21C9-4667-8324-1786CA895420Q53764455-B4386BE8-3325-4763-BB97-A0C6F9655203Q61810318-BB58989B-3624-46DB-8ED2-6F78C4FC71BFQ83563765-A209EA0E-D0BD-484F-94C5-9FA1A2030388Q93048038-EBC824AE-03C1-4655-9F46-A6EEE7FA26C1
P50
description
researcher
@en
wetenschapper
@nl
name
Ahmed Ihab Abdelaziz
@en
Ahmed Ihab Abdelaziz
@nl
type
label
Ahmed Ihab Abdelaziz
@en
Ahmed Ihab Abdelaziz
@nl
prefLabel
Ahmed Ihab Abdelaziz
@en
Ahmed Ihab Abdelaziz
@nl
P106
P31
P496
0000-0002-3367-2247